| Bioactivity | Substance P Receptor Antagonist 1 has the potential function in central nervous system disorders, respiratory, inflammatory diseases and gastrointestinal disorders. |
| Invitro | Substance P Receptor Antagonist 1 has the potential function in numerous diseases, including central nervous system disorders such as depression, anxiety and schizophrenia, in respiratory and inflammatory diseases such as asthma and rheumatoid arthritis, in gastrointestinal disorders and diseases of the GI tract such as ulcerative colitis and Crohn's disease, and in the transmission of pain, including migraine[1]. |
| Name | Substance P Receptor Antagonist 1 |
| CAS | 225526-17-0 |
| Formula | C24H29F3N2O2 |
| Molar Mass | 434.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Caron, Stephane, et al. Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds. EP1095939 A2. |
Substance P Receptor Antagonist 1
CAS: 225526-17-0 F: C24H29F3N2O2 W: 434.49
Substance P Receptor Antagonist 1 has the potential function in central nervous system disorders, respiratory, inflammat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.